Sleep and breathing disorders represent a significant and often under-recognized component of respiratory medicine, encompassing conditions such as obstructive sleep apnea, central sleep apnea, hypoventilation syndromes, and nocturnal hypoxemia. The sleep and breathing disorders consultant plays a central role in integrating diagnostic evaluation, therapeutic planning, and longitudinal follow-up to optimize patient outcomes. Polysomnography, home sleep testing, capnography, and nocturnal oximetry constitute essential tools that inform individualized treatment strategies. Beyond diagnostics, the consultant applies evidence-based interventions including continuous positive airway pressure (CPAP) therapy, adaptive servo-ventilation, positional therapy, and advanced oral appliance management, tailored to the physiological and behavioral characteristics of each patient. Interdisciplinary collaboration with cardiologists, neurologists, pulmonologists, and behavioral health specialists is essential to address comorbidities and enhance adherence to therapy. Technological advancements, including automated titration devices, telemonitoring, and AI-assisted sleep data analysis, have improved treatment precision and patient engagement. In addition to clinical responsibilities, consultants contribute to institutional program development, standardizing sleep laboratory protocols, ensuring compliance with regulatory guidelines, and evaluating outcomes metrics. By combining clinical expertise, technological integration, and structured care pathways, a sleep and breathing disorders consultant ensures accurate diagnosis, effective therapy implementation, and ongoing monitoring, ultimately improving functional health, mitigating risk of cardiopulmonary complications, and promoting restorative sleep as a cornerstone of comprehensive respiratory care.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation